Dynamic Augmentation of Left Ventricle and Mitral Valve Function With an Implantable Soft Robotic Device

JACC Basic Transl Sci. 2020 Feb 26;5(3):229-242. doi: 10.1016/j.jacbts.2019.12.001. eCollection 2020 Mar.

Abstract

Left ventricular failure is strongly associated with secondary mitral valve regurgitation. Implantable soft robotic devices are an emerging technology that enables augmentation of a native function of a target tissue. We demonstrate the ability of a novel soft robotic ventricular assist device to dynamically augment left ventricular contraction, provide native pulsatile flow, simultaneously reshape the mitral valve apparatus, and eliminate the associated regurgitation in an Short-term large animal model of acute left ventricular systolic dysfunction.

Keywords: FS, fractional shortening; HF, heart failure; IQR, interquartile range; IVS, interventricular septum; LHF, left heart failure; LV, left ventricular; LVEDP, left ventricular end-diastolic pressure; LVSD, left ventricular systolic dysfunction; MV, mitral valve; MVR, mitral valve regurgitation; RV, right ventricle; SRVAD, soft robotic ventricular assist device; left ventricular systolic dysfunction; mitral valve; secondary mitral regurgitation; soft robotic.